Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J MacEwan

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
Blood|December 6, 2013
Identification of Bruton's tyrosine kinase as a therapeutic target in acute myeloid leukemiaStuart A Rushworth, Megan Y Murray, Lyubov Zaitseva, et al.
Oncotarget|September 14, 2011
Protection of acute myeloid leukaemia cells from apoptosis induced by front-line chemotherapeutics is mediated by haem oxygenase-1Sally-Anne Heasman, Lyubov Zaitseva, Kristian M Bowles, et al.
Oncotarget|September 14, 2013
Understanding the role of NRF2-regulated miRNAs in human malignanciesNiraj M Shah, Stuart A Rushworth, Megan Y Murray, et al.
Biochimica Et Biophysica Acta|August 5, 2003
The influence of alkyl pyridinium sponge toxins on membrane properties, cytotoxicity, transfection and protein expression in mammalian cellsSteven J Tucker, David McClelland, Marcel Jaspars, et al.
Cellular Signalling|September 15, 2012
BTK inhibitor ibrutinib is cytotoxic to myeloma and potently enhances bortezomib and lenalidomide activities through NF-κBStuart A Rushworth, Kristian M Bowles, Lawrence N Barrera, et al.
BMC Biotechnology|January 18, 2006
Pore forming polyalkylpyridinium salts from marine sponges versus synthetic lipofection systems: distinct tools for intracellular delivery of cDNA and siRNADebra McLaggan, Noppadon Adjimatera, Kristina Sepcić, et al.
American Journal of Cancer Research|December 30, 2011
Understanding the role of miRNA in regulating NF-κB in blood cancerStuart A Rushworth, Megan Y Murray, Lawrence N Barrera, et al.
Blood|October 19, 2012
The high Nrf2 expression in human acute myeloid leukemia is driven by NF-κB and underlies its chemo-resistanceStuart A Rushworth, Lyubov Zaitseva, Megan Y Murray, et al.
Scientific Reports|August 22, 2015
Targeting BTK for the treatment of FLT3-ITD mutated acute myeloid leukemiaGenevra Pillinger, Amina Abdul-Aziz, Lyubov Zaitseva, et al.
The Biochemical Journal|May 9, 2002
Tumour necrosis factor-induced activation of c-Jun N-terminal kinase is sensitive to caspase-dependent modulation while activation of mitogen-activated protein kinase (MAPK) or p38 MAPK is notAhmed A A Mohamed, Orla J Jupp, Helen M Anderson, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Blood|December 6, 2013
Identification of Bruton's tyrosine kinase as a therapeutic target in acute myeloid leukemiaStuart A Rushworth, Megan Y Murray, Lyubov Zaitseva, et al.
Oncotarget|September 14, 2011
Protection of acute myeloid leukaemia cells from apoptosis induced by front-line chemotherapeutics is mediated by haem oxygenase-1Sally-Anne Heasman, Lyubov Zaitseva, Kristian M Bowles, et al.
Oncotarget|September 14, 2013
Understanding the role of NRF2-regulated miRNAs in human malignanciesNiraj M Shah, Stuart A Rushworth, Megan Y Murray, et al.
Biochimica Et Biophysica Acta|August 5, 2003
The influence of alkyl pyridinium sponge toxins on membrane properties, cytotoxicity, transfection and protein expression in mammalian cellsSteven J Tucker, David McClelland, Marcel Jaspars, et al.
Cellular Signalling|September 15, 2012
BTK inhibitor ibrutinib is cytotoxic to myeloma and potently enhances bortezomib and lenalidomide activities through NF-κBStuart A Rushworth, Kristian M Bowles, Lawrence N Barrera, et al.
BMC Biotechnology|January 18, 2006
Pore forming polyalkylpyridinium salts from marine sponges versus synthetic lipofection systems: distinct tools for intracellular delivery of cDNA and siRNADebra McLaggan, Noppadon Adjimatera, Kristina Sepcić, et al.
American Journal of Cancer Research|December 30, 2011
Understanding the role of miRNA in regulating NF-κB in blood cancerStuart A Rushworth, Megan Y Murray, Lawrence N Barrera, et al.
Blood|October 19, 2012
The high Nrf2 expression in human acute myeloid leukemia is driven by NF-κB and underlies its chemo-resistanceStuart A Rushworth, Lyubov Zaitseva, Megan Y Murray, et al.
Scientific Reports|August 22, 2015
Targeting BTK for the treatment of FLT3-ITD mutated acute myeloid leukemiaGenevra Pillinger, Amina Abdul-Aziz, Lyubov Zaitseva, et al.
The Biochemical Journal|May 9, 2002
Tumour necrosis factor-induced activation of c-Jun N-terminal kinase is sensitive to caspase-dependent modulation while activation of mitogen-activated protein kinase (MAPK) or p38 MAPK is notAhmed A A Mohamed, Orla J Jupp, Helen M Anderson, et al.
Pageof 6